arrow
A

Agrima Mian

University System of Ohio
H指数:11
被引数:647

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Neighborhood socioeconomic disadvantage and distance from treatment center do not impact survival outcomes of patients with non-Hodgkin lymphoma and multiple myeloma treated with CAR T-cell therapies.

社区社会经济劣势和距离治疗中心的距离不影响接受CAR T细胞疗法治疗的非霍奇金淋巴瘤和多发性骨髓瘤患者的生存结局。

2026-06-100
PRE
Assessment of Fellowship Didactic Curricula in Hematology/Oncology: Cross-Sectional Findings From the PODCAST-HOF Trial

血液病学/肿瘤学奖学金指导课程评估:PODCAST-HOF试验的横断面研究结果

2026-02-010
PRE
Is CAR T a drug or a therapeutic pathway? Intention to treat versus per protocol analysis of real world studies of CAR-T cell therapy in relapsed refractory diffuse large B cell lymphoma
2024-11-070
OAAI
BEAM versus pharmacokinetics-directed BuCyVP16 conditioning for patients with peripheral T-cell lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation
2024-03-251
OAAI
A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma
2023-07-1322
OAAI
A population level analysis of second hematological malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma survivors in the era of targeted therapies

在靶向治疗时代,慢性淋巴细胞白血病/小淋巴细胞淋巴瘤幸存者的第二血液系统恶性肿瘤的人群水平分析

2023-06-130
OAAI
Influence of Killer Immunoglobulin-Like Receptors and Somatic Mutations on Transplant Outcomes in Acute Myeloid Leukemia
2021-11-012
OAAI
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis
2021-07-2027
OA